The effect of catheter displacement on acute and late toxicity in fractionated HDR monotherapy of prostate cancer

被引：0
|
作者：
Aluwini, S. [1 ]
Bhawanie, A. [1 ]
Baartman, L. [1 ]
Alemayehu, W. Ghidey [2 ]
Busser, W. [1 ]
Boormans, J. [3 ]
Kolkman-Deurloo, I. K. [1 ]
机构：
[1] Erasmus MC, Dept Radiat Oncol, Inst Canc, Rotterdam, Netherlands
[2] Erasmus MC, Clin Trials Ctr, Inst Canc, Rotterdam, Netherlands
[3] Erasmus MC, Inst Canc, Dept Urol, Rotterdam, Netherlands
来源：
RADIOTHERAPY AND ONCOLOGY | 2015年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OC-0036
引用
收藏
页码：S17 / S18
页数：2
相关论文
共 50 条
  • [31] Acute and late toxicity patterns of moderate hypo-fractionated radiotherapy for prostate cancer: A systematic review and meta-analysis
    Sinzabakira, F.
    Brand, V.
    Heemsbergen, W. D.
    Incrocci, L.
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2023, 40
  • [32] Needle displacement during HDR brachytherapy in the treatment of prostate cancer
    Damore, SJ
    Syed, AMN
    Puthawala, AA
    Sharma, A
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (05): : 1205 - 1211
  • [33] HDR brachytherapy as monotherapy for prostate cancer: comparison of two fractionation schedules
    Stankiewicz, Magdalena
    Hasterok, Maja
    Szoltysik, Monika
    Kellas-Sleczka, Sylwia
    Szlag, Marta
    Wojcieszek, Piotr
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S410 - S412
  • [34] Long-term results of HDR monotherapy in the treatment of prostate cancer
    Yoshioka, Y.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S181 - S182
  • [35] Acute toxicity of HDR-brachytherapy as monotherapy for low-risk prostate cancer: Analysis of 297 patients treated with two different fractionation schemes
    Skazikis, G.
    Kurek, R.
    Baltas, D.
    Tselis, N.
    Dankwart, R.-O.
    Tunn, U.-W.
    Zamboglou, N.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2007, 183 : 125 - 125
  • [36] Combined curative radiotherapy including HDR brachytherapy and androgen deprivation in localized prostate cancer:: A prospective assessment of acute and late treatment toxicity
    Wahlgren, T
    Nilsson, S
    Ryberg, M
    Lennernäs, B
    Brandberg, Y
    ACTA ONCOLOGICA, 2005, 44 (06) : 633 - 643
  • [37] PSA outcomes and late toxicity of single-fraction HDR brachytherapy and LDR brachytherapy as monotherapy in localized prostate cancer: A phase 2 randomized pilot study
    Reynaud, Thomas
    Hathout, Lara
    Carignan, Damien
    Barkati, Maroie
    Martin, Andre-Guy
    Foster, William
    Lacroix, Frederic
    Delouya, Guila
    Taussky, Daniel
    Morton, Gerard
    Vigneault, Eric
    BRACHYTHERAPY, 2021, 20 (06) : 1090 - 1098
  • [38] THE INFLUENCE OF DOSIMETRY ON ACUTE URINARY TOXICITY IN HDR PROSTATE BRACHYTHERAPY
    El-Bared, Nancy
    Desrashodian, Talar
    Wakil, Georges
    Mondat, Marise
    Berbiche, Djamal
    Jolicoeur, Marjorie
    RADIOTHERAPY AND ONCOLOGY, 2016, 120 : S53 - S53
  • [39] THE DOSIMETRIC SIGNIFICANCE OF CATHETER DISPLACEMENT IN PROSTATE HIGH DOSE-RATE (HDR) BRACHYTHERAPY
    Soliman, H.
    Sankreacha, R.
    Hunt, D.
    Loblaw, A.
    Morton, G.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S32 - S32
  • [40] Catheter displacement and dosimetry for single fraction MRI guided focal prostate HDR brachytherapy
    Maenhout, M.
    van Zyp, J. R. N. Van der Voort
    Peters, M.
    Van Vulpen, M.
    Moerland, M. A.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 : S16 - S17
12345